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INTRODUCTION AND OBJECTIVES: 
• Myxoidliposarcoma (MLS) has a 
propensity to metastasize to osseous sites. 
• Reports in the literature suggest that FDG-
PET, CT, and bone scan are insensitive 
and that MRI is the preferred modality for 
detecting metastatic disease in the bone 
marrow. 
• Whole body MRI (WBMRI) is relatively 
time consuming to perform when multiple 
sequences are used with standard 
equipment.  
• We present our initial experience utilizing 
WBMRI to evaluate for metastatic MLS 
and propose whole body STIR sequences 
as a methodology for screening for 
metastatic disease.  
 
METHODS: A retrospective review of all 
patients with MLS who underwent whole 
body 1.5T or 3T MRI examinations between 
2012 and 2018.  
WBMRI included T1, T2, STIR, T1 fat 
suppressed, and T1 fat suppressed with 
contrast. 
After initial staging, patients were followed 
with WBMRI with STIR imaging only. 
Large-field coronal views of the long bones, 
ribs, chest, scapulae, pelvis with sagittal view 
of the spine. 
All patients underwent additional imaging 
with a CT chest, abdomen, and pelvis, whole 
body PET-CT and whole body bone scan.  
Identified lesions were further evaluated with 
dedicated MRI of the site 
The number and locations of the sites found 
by imaging as well as the round cell 
component of the sites sampled were 
evaluated. 
Metastases were confirmed by pathology or 
progression on subsequent MRIs. 
 
RESULTS: We found a total of 68 osseous 
only lesions, including 8 osseous lesions 
extending into the surrounding soft tissues by 
MRI. 
None of the osseous only lesions were 
detected by FDG-PET or CT. 
FDG-PET and CT were able to identify only 
some of the osseous lesions that extended 
outside of the bone. 
No pulmonary metastases were found. 
STIR and T1 fat suppressed contrast 
enhanced images were found to provide the 
best contrast of the metastases compared to 
the normal bone marrow. 
Of the tumors resected in the patients with 
metastatic disease, 3 of the primary tumors 
had a round cell component of 0%, 1 of 2-5%, 
1 of 5-10% and 1 of 20%. Ten of the 
metastatic lesions resected did not have any 
round cell component.  
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Average imaging time for WBMRI was 250 
minutes of scan time vs. 41 minutes for STIR 
WBMRI (83.6% reduction in total time). 
STIR WBMRI was tolerated by all patients in 
one session. No patient was able to tolerate 
standard WBMRI in one session. 
 
CONCLUSIONS: Metastatic MLS is most 
reliably detected on WBMRI.  
We found that imaging the whole body with 
standard WBMRI to be a resource and time 
consuming endeavor.  
Metastatic MLS is best visualized on STIR 
and T1 contrast images. 
Utilizing STIR only WBMRI has markedly 
decreased imaging time by 83.6%, which is 
better tolerated by our patients and decreases 
the utilization time of the MRI.  
The use of STIR imaging is preferred as this 
avoids complications that may occur with 
administering contrast.  
Despite a low round cell component, 
metastatic lesions were identified in our 
patients. Due to this, we advocate that all 
patients diagnosed with MLS obtain a 
WBMRI with STIR sequences for both 
staging and screening, regardless of round 
cell component. 
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